Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
27.75
-0.57 (-2.01%)
Jun 3, 2025, 1:18 PM - Market open
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $201.85 million as of June 3, 2025. Its market cap has increased by 1,610.85% in one year.
Market Cap
201.85M
Enterprise Value
161.32M
1-Year Change
1,610.85%
Ranking
Category
Stock Price
$27.75
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $201.85M, an increase of 383.09%. That is a compound annual growth rate of 44.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2025 | 201.85M | -19.47% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.36B |
| Johnson & Johnson | 370.85B |
| AbbVie | 328.87B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 276.77B |
| Abbott Laboratories | 231.80B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |